Literature DB >> 32578144

IPSC Models of Chromosome 15Q Imprinting Disorders: From Disease Modeling to Therapeutic Strategies.

Noelle D Germain1, Eric S Levine2, Stormy J Chamberlain1.   

Abstract

The chromosome 15q11-q13 region of the human genome is regulated by genomic imprinting, an epigenetic phenomenon in which genes are expressed exclusively from one parental allele. Several genes within the 15q11-q13 region are expressed exclusively from the paternally inherited chromosome 15. At least one gene UBE3A, shows exclusive expression of the maternal allele, but this allele-specific expression is restricted to neurons. The appropriate regulation of imprinted gene expression across chromosome 15q11-q13 has important implications for human disease. Three different neurodevelopmental disorders result from aberrant expression of imprinted genes in this region: Prader-Willi syndrome (PWS), Angelman syndrome (AS), and 15q duplication syndrome.

Entities:  

Keywords:  Angelman syndrome; Antisense oligonucleotides; Chromosome 15q11-q13; Dup15q syndrome; Genomic imprinting; Prader–Willi syndrome; UBE3A

Mesh:

Year:  2020        PMID: 32578144      PMCID: PMC9305669          DOI: 10.1007/978-3-030-45493-7_3

Source DB:  PubMed          Journal:  Adv Neurobiol


  98 in total

1.  A human imprinting centre demonstrates conserved acquisition but diverged maintenance of imprinting in a mouse model for Angelman syndrome imprinting defects.

Authors:  Karen A Johnstone; Amanda J DuBose; Christopher R Futtner; Michael D Elmore; Camilynn I Brannan; James L Resnick
Journal:  Hum Mol Genet       Date:  2005-12-20       Impact factor: 6.150

2.  Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2.

Authors:  Simone Kühnle; Ulrike Kogel; Sandra Glockzin; Andreas Marquardt; Aaron Ciechanover; Konstantin Matentzoglu; Martin Scheffner
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

3.  Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome.

Authors:  Hanoch Kaphzan; Shelly A Buffington; Joo In Jung; Matthew N Rasband; Eric Klann
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

4.  Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.

Authors:  Sara Silva-Santos; Geeske M van Woerden; Caroline F Bruinsma; Edwin Mientjes; Mehrnoush Aghadavoud Jolfaei; Ben Distel; Steven A Kushner; Ype Elgersma
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

5.  The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome.

Authors:  Yonatan Stelzer; Ido Sagi; Ofra Yanuka; Rachel Eiges; Nissim Benvenisty
Journal:  Nat Genet       Date:  2014-05-11       Impact factor: 38.330

6.  A targeted deletion upstream of Snrpn does not result in an imprinting defect.

Authors:  Edwin G Peery; Michael D Elmore; James L Resnick; Camilynn I Brannan; Karen A Johnstone
Journal:  Mamm Genome       Date:  2007-05-19       Impact factor: 3.224

7.  The interstitial duplication 15q11.2-q13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature.

Authors:  Nora Urraca; Julie Cleary; Victoria Brewer; Eniko K Pivnick; Kathryn McVicar; Ronald L Thibert; N Carolyn Schanen; Carmen Esmer; Dustin Lamport; Lawrence T Reiter
Journal:  Autism Res       Date:  2013-03-14       Impact factor: 5.216

8.  RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery.

Authors:  Walt F Lima; Cheryl L De Hoyos; Xue-hai Liang; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2016-02-03       Impact factor: 16.971

9.  Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome.

Authors:  Joseph Polex-Wolf; Brian Yh Lam; Rachel Larder; John Tadross; Debra Rimmington; Fàtima Bosch; Verónica Jiménez Cenzano; Eduard Ayuso; Marcella Kl Ma; Kara Rainbow; Anthony P Coll; Stephen O'Rahilly; Giles Sh Yeo
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

10.  Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome.

Authors:  Hyeong-Min Lee; Ellen P Clark; M Bram Kuijer; Mark Cushman; Yves Pommier; Benjamin D Philpot
Journal:  Mol Autism       Date:  2018-08-17       Impact factor: 7.509

View more
  1 in total

Review 1.  Neurodevelopmental copy-number variants: A roadmap to improving outcomes by uniting patient advocates, researchers, and clinicians for collective impact.

Authors: 
Journal:  Am J Hum Genet       Date:  2022-08-04       Impact factor: 11.043

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.